• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bayer Aktienges ADR (OP: BAYRY )

    7.460 UNCHANGED
    Streaming Delayed Price Updated: 12:21 PM EDT, Jul 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 434,778
    Open 7.400
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 7.460
    Today's Range 7.390 - 7.480
    52wk Range 6.820 - 14.70
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer
    Australian judge dismisses class action lawsuit against Bayer for Roundup causing cancer. Ruling supports company's stance that product is safe. 
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Glyphosate Legal
    ScottsMiracle-Gro Stock Blooms After Investor Day Optimism
    Lawn and garden products manufacturer ScottsMiracle-Gro Co. (NYSE: SMG) stock surged on its Investor Day update ahead of fiscal Q3 2024 earnings release. 
    Via MarketBeat
    Topics Cannabis
    Exposures Cannabis

    Performance

    YTD
    -20.47%
    -20.47%
    1 Month
    +6.42%
    +6.42%
    3 Month
    +2.61%
    +2.61%
    6 Month
    -15.99%
    -15.99%
    1 Year
    -47.61%
    -47.61%

    More News

    Read More
    3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
    Via InvestorPlace
    3 Small-Cap Stocks With Explosive 2X Growth Potential
    Via InvestorPlace
    Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
    Via Benzinga
    Exposures Glyphosate
    Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership
    Via Talk Markets
    European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday?
    Via Benzinga
    After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
    Via Benzinga
    Topics Data Breach
    Exposures Information Security
    Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
    Via Benzinga
    Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
    Via Benzinga
    BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
    Via Benzinga
    Exposures Glyphosate
    Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'
    Via Benzinga
    Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
    Via Benzinga
    Topics Bonds
    Exposures Debt Markets
    Bayer-Backed Boundless Bio Falls After IPO
    Via Talk Markets
    Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
    Via AB Newswire
    Topics Supply Chain
    Exposures Supply Chain
    Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
    Via Benzinga
    Exposures Product Safety
    German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
    Via Benzinga
    Topics Bankruptcy Lawsuit
    Exposures Financial Glyphosate Legal
    BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges
    Via Benzinga
    Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
    Via InvestorPlace
    What's Going On With BridgeBio Pharma Stock On Monday?
    Via Benzinga
    Exposures Product Safety
    BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out?
    Via Investor's Business Daily
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.